Back to search
FDAFDA · Food and drugs·Recall number D-385-2014

Dexedrine® (Dextroamphetamine Sulfate) Spansules® Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09

Published January 1, 2014 · Recall initiated: October 7, 2013

Summary

FDA records drug Class II recall D-385-2014, published January 1, 2014 and initiated October 7, 2013. Recalling firm: Amedra Pharmaceuticals LLC; Status: Terminated; Reported quantity: 10,992 bottles; Lot: Lot# 243459; Exp. 01/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amedra Pharmaceuticals LLC
Distributor
Nationwide
Lot
Lot# 243459; Exp. 01/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexedrine® (Dextroamphetamine Sulfate) Spansules® Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09 recalled?

Yes. FDA published recall D-385-2014 on January 1, 2014. Reported hazard: Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.

What should I do if I have this product?

Voluntary: Firm initiated · Letter